title: Leptin receptor (Ob-R) mRNA expression and serum leptin concentration in patients with colorectal and metastatic colorectal cancer.
abstract: The objective of the present study was to investigate the effect of leptin on the progression of colorectal carcinoma to metastatic disease by analyzing the serum leptin concentration and Ob-R gene expression in colon cancer tissues. Tissue samples were obtained from 31 patients who underwent surgical resection for colon (18 cases) and metastatic colon (13 cases) cancer. Serum leptin concentration was determined by an enzyme-linked immunosorbent assay (ELISA) and Ob-R mRNA expression by real-time polymerase chain reaction (RT-PCR) for both groups. ELISA data were analyzed by the Student t-test and RT-PCR data were analyzed by the Mann-Whitney U-test. RT-PCR results demonstrated that mRNA expression of Ob-R in human metastatic colorectal cancer was higher than in local colorectal cancer tissues. On the other hand, mean serum leptin concentration was significantly higher in local colorectal cancer patients compared to patients with metastatic colorectal cancer. The results of the present study suggest a role for leptin in the progression of colon cancer to metastatic disease without weight loss. In other words, significantly increased Ob-R mRNA expression and decreased serum leptin concentration in patients with metastatic colon cancer indicate that sensitization to leptin activity may be a major indicator of metastasis to the colon tissue and the determination of leptin concentration and leptin gene expression may be used to aid the diagnosis.
authors.affiliation: Department of Physiology, Osmangazi University Medical Faculty, Meselik, Eskisehir, Turkey. nerkasap@gmail.com
authors.forename: N
authors.initials: N
authors.lastname: Erkasap
authors.forename: M
authors.initials: M
authors.lastname: Ozkurt
authors.forename: S
authors.initials: S
authors.lastname: Erkasap
authors.forename: F
authors.initials: F
authors.lastname: Yasar
authors.forename: K
authors.initials: K
authors.lastname: Uzuner
authors.forename: E
authors.initials: E
authors.lastname: Ihtiyar
authors.forename: S
authors.initials: S
authors.lastname: Uslu
authors.forename: M
authors.initials: M
authors.lastname: Kara
authors.forename: O
authors.initials: O
authors.lastname: Bolluk
mesh_terms: D000368:Aged; D015179:Colorectal Neoplasms / Q000097:blood / Q000378:metabolism* / Q000473:pathology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015870:Gene Expression; D006801:Humans; D020738:Leptin / Q000097:blood* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012333:RNA, Messenger / Q000032:analysis; D060888:Real-Time Polymerase Chain Reaction; D054411:Receptors, Leptin / Q000032:analysis* / Q000097:blood / Q000235:genetics
chemical_list: D020738:Leptin; D012333:RNA, Messenger; D054411:Receptors, Leptin
references.citation: Clin Cancer Res. 2004 Jul 1;10(13):4325-31
references.pmid: 15240518
references.citation: J Biol Chem. 2004 Apr 16;279(16):16495-502
references.pmid: 14752104
references.citation: J Immunol. 2007 Feb 1;178(3):1774-82
references.pmid: 17237427
references.citation: Ann Surg Oncol. 2009 Feb;16(2):297-303
references.pmid: 19050975
references.citation: Gut. 2005 Aug;54(8):1136-45
references.pmid: 15857934
references.citation: Tumori. 2002 Mar-Apr;88(2):147-9
references.pmid: 12088256
references.citation: Acta Diabetol. 2012 Dec;49 Suppl 1:S205-14
references.pmid: 22987225
references.citation: Anticancer Res. 2011 Oct;31(10):3381-3
references.pmid: 21965750
references.citation: Int J Oncol. 2011 Oct;39(4):935-40
references.pmid: 21720710
references.citation: FASEB J. 2000 Nov;14(14):2329-38
references.pmid: 11053255
references.citation: Rev Esp Enferm Dig. 2007 Apr;99(4):201-5
references.pmid: 17590101
references.citation: Peptides. 2003 Aug;24(8):1181-7
references.pmid: 14612189
references.citation: Gastroenterology. 2001 Jul;121(1):79-90
references.pmid: 11438496
references.citation: Gut. 2011 Oct;60(10):1363-71
references.pmid: 21406387
references.citation: Int J Oncol. 2001 Nov;19(5):1009-14
references.pmid: 11605002
references.citation: Cell Biochem Biophys. 2011 Jul;60(3):241-4
references.pmid: 21161731
references.citation: Am J Physiol. 1998 Dec;275(6):R2056-60
references.pmid: 9843897
references.citation: Mol Biol Rep. 2011 Apr;38(4):2219-23
references.pmid: 20857202
references.citation: J Clin Pathol. 2007 Aug;60(8):902-6
references.pmid: 17660334
references.citation: BMC Cancer. 2011 Jul 19;11:303
references.pmid: 21771332